DarioHealth Corp. (DRIO) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -31.83M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | 8.79M USD | Cost of Goods and Services Sold |
| Research and development | 10.45M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-31.83M | (m) | $8.79M | $10.45M | (m) | (m) |
| 2026-03-31 | $-34.55M | (m) | $9.21M | $12.07M | (m) | (m) |
| 2025-12-31 | $-36.66M | (m) | $9.69M | $13.79M | (m) | (m) |
| 2025-09-30 | $-39.76M | (m) | $10.67M | $16.44M | (m) | (m) |
| 2025-06-30 | $-42.31M | (m) | $12.22M | $18.56M | (m) | (m) |
| 2025-03-31 | $-49.30M | (m) | $13.32M | $21.64M | (m) | (m) |
| 2024-12-31 | $-57.74M | (m) | $13.77M | $24.18M | (m) | (m) |
| 2024-09-30 | $-60.29M | (m) | $13.86M | $23.09M | (m) | (m) |
| 2024-06-30 | $-63.81M | (m) | $13.22M | $23.31M | (m) | (m) |
| 2024-03-31 | $-61.64M | (m) | $13.80M | $21.73M | (m) | (m) |
| 2023-12-31 | $-56.19M | (m) | $14.37M | $20.25M | (m) | (m) |
| 2023-09-30 | $-50.98M | (m) | $14.96M | $20.83M | (m) | (m) |
| 2023-06-30 | $-50.01M | (m) | $16.86M | $19.97M | (m) | (m) |
| 2023-03-31 | $-53.35M | (m) | $17.82M | $18.89M | (m) | (m) |
| 2022-12-31 | $-56.81M | (m) | $18.00M | $19.65M | (m) | (m) |
| 2022-09-30 | $-69.47M | (m) | $15.30M | $20.18M | (m) | (m) |
| 2022-06-30 | $-77.39M | (m) | $14.37M | $20.89M | (m) | (m) |
| 2022-03-31 | $-78.04M | (m) | $13.60M | $20.49M | (m) | (m) |
| 2021-12-31 | $-76.49M | (m) | $12.44M | $17.22M | (m) | (m) |
| 2021-09-30 | $-63.89M | (m) | $9.28M | $13.33M | (m) | (m) |
| 2021-06-30 | $-48.00M | (m) | $7.67M | $8.77M | (m) | (m) |
| 2021-03-31 | $-34.12M | (m) | $6.16M | $5.86M | (m) | (m) |
| 2020-12-31 | $-29.90M | (m) | $5.06M | $4.43M | (m) | (m) |
| 2020-09-30 | $-25.02M | (m) | $4.49M | $3.85M | (m) | (m) |
| 2020-06-30 | $-21.22M | (m) | $3.99M | $3.75M | (m) | (m) |
| 2020-03-31 | $-22.46M | (m) | $4.17M | $3.92M | (m) | (m) |
| 2019-12-31 | $-17.70M | (m) | $4.96M | $3.69M | (m) | (m) |
| 2019-09-30 | $-18.45M | (m) | $5.48M | $3.78M | (m) | (m) |
| 2019-06-30 | $-19.70M | $7.47M | $5.90M | $3.92M | (m) | -263.72% |
| 2019-03-31 | $-20.14M | $7.88M | $6.11M | $3.94M | (m) | -255.53% |
| 2018-12-31 | $-17.69M | $7.39M | $5.63M | $3.68M | (m) | -239.22% |
| 2018-09-30 | $-15.65M | $7.27M | (m) | $3.60M | (m) | -215.21% |
| 2018-06-30 | $-14.70M | $6.77M | (m) | $3.40M | (m) | -217.17% |
| 2018-03-31 | $-13.09M | $5.92M | (m) | $3.57M | (m) | -221.14% |
| 2017-12-31 | $-14.42M | $5.17M | (m) | $3.30M | (m) | -278.90% |
| 2017-09-30 | $-15.14M | $4.43M | (m) | $3.03M | (m) | -341.67% |
| 2017-06-30 | $-14.88M | $3.78M | (m) | $2.89M | (m) | -393.29% |
| 2017-03-31 | $-13.38M | $3.24M | (m) | $2.23M | (m) | -412.80% |
| 2016-12-31 | $-11.10M | $2.80M | (m) | $2.15M | (m) | -396.04% |
| 2016-09-30 | $-9.13M | $2.27M | (m) | $2.15M | (m) | -401.63% |
| 2016-06-30 | $-8.96M | $1.82M | (m) | $2.16M | (m) | -492.57% |
| 2016-03-31 | $-7.84M | $1.32M | (m) | $2.08M | (m) | -592.45% |
| 2015-12-31 | $-7.70M | $823.00K | (m) | $2.56M | (m) | -935.36% |
| 2015-09-30 | $-8.42M | $566.00K | (m) | $2.73M | (m) | -1486.93% |
| 2015-06-30 | $-8.38M | $293.00K | (m) | $2.83M | (m) | -2858.70% |
| 2015-03-31 | $-10.47M | $118.00K | (m) | $3.72M | (m) | -8870.34% |
| 2014-12-31 | $-11.36M | $51.00K | (m) | $3.94M | (m) | -22270.59% |
| 2014-09-30 | $-12.43M | (m) | (m) | $4.95M | (m) | (m) |
| 2014-06-30 | $-13.16M | (m) | (m) | $5.26M | (m) | (m) |
| 2014-03-31 | $-13.15M | (m) | (m) | $5.33M | (m) | (m) |
| 2013-12-31 | $-13.56M | (m) | (m) | $4.91M | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-3.97M | (m) | (m) | $1.50M | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |